Activity: Membership types › Membership of network
Description
PREDICT-Meso (PRE-malignant Drivers Combined with Target-Drug validation in Mesothelioma) is an international network of researchers across the UK, Spain, Italy and Belgium interested in the study of Malignant Pleural Mesothelioma (MPM). MPM is preceded by decades of pleural inflammation providing a window of opportunity for precision prediction and early treatment that the Network wishes to explore. Together the teams hope to better understand how MPM develops from its early stages and translate this into more effective diagnosis and treatment for patients.